Historical trend toward improved long-term outcome in childhood absence epilepsy

Elliot Morse, Kathryn Giblin, Mi Hae Chung, Carolin Dohle, Anne T. Berg, Hal Blumenfeld

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We retrospectively analyzed published studies to investigate historical trends in outcome of childhood absence epilepsy (CAE). We included patients based on onset of absence seizures in childhood, 3 Hz bilateral spike-wave discharges on EEG, and availability of seizure-free outcome data. The primary endpoint was seizure-freedom off medications by study publication year. We also analyzed relationships between seizure-freedom and 1. treatment medication, and 2. CAE diagnostic criteria. We included 29 studies published 1945–2013, encompassing 2416 patients. Seizure-freedom off medications was higher for studies after 1985 versus before 1975 (82% versus 35%; p < 0.001). Ethosuximide and valproate were used more commonly after 1985, and patients previously treated with ethosuximide or valproate had higher seizure-freedom off medications than those treated only with other medications (64% versus 32%; χ 2 >10; p < 0.001). Although differences in diagnostic criteria for early vs. later studies did not reach statistical significance, later studies tended to use normal EEG background (p = 0.09) and absence of comorbid disorders (p = 0.09) as criteria more commonly. These findings demonstrate that seizure-freedom off medications has improved in published CAE studies after 1985. Our results are limited due to retrospective analysis. Further work is needed with prospective, controlled trials to establish factors leading to improved long-term prognosis in CAE.

Original languageEnglish (US)
Pages (from-to)7-10
Number of pages4
JournalEpilepsy Research
Volume152
DOIs
StatePublished - May 2019
Externally publishedYes

Fingerprint

Absence Epilepsy
Seizures
Electroencephalography
Publications

Keywords

  • Childhood absence epilepsy
  • Epileptogenesis
  • Ethosuximide
  • Prognosis
  • Valproate

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Historical trend toward improved long-term outcome in childhood absence epilepsy. / Morse, Elliot; Giblin, Kathryn; Chung, Mi Hae; Dohle, Carolin; Berg, Anne T.; Blumenfeld, Hal.

In: Epilepsy Research, Vol. 152, 05.2019, p. 7-10.

Research output: Contribution to journalArticle

Morse, Elliot ; Giblin, Kathryn ; Chung, Mi Hae ; Dohle, Carolin ; Berg, Anne T. ; Blumenfeld, Hal. / Historical trend toward improved long-term outcome in childhood absence epilepsy. In: Epilepsy Research. 2019 ; Vol. 152. pp. 7-10.
@article{b416fe84fb1747d2892e5ca2875c1855,
title = "Historical trend toward improved long-term outcome in childhood absence epilepsy",
abstract = "We retrospectively analyzed published studies to investigate historical trends in outcome of childhood absence epilepsy (CAE). We included patients based on onset of absence seizures in childhood, 3 Hz bilateral spike-wave discharges on EEG, and availability of seizure-free outcome data. The primary endpoint was seizure-freedom off medications by study publication year. We also analyzed relationships between seizure-freedom and 1. treatment medication, and 2. CAE diagnostic criteria. We included 29 studies published 1945–2013, encompassing 2416 patients. Seizure-freedom off medications was higher for studies after 1985 versus before 1975 (82{\%} versus 35{\%}; p < 0.001). Ethosuximide and valproate were used more commonly after 1985, and patients previously treated with ethosuximide or valproate had higher seizure-freedom off medications than those treated only with other medications (64{\%} versus 32{\%}; χ 2 >10; p < 0.001). Although differences in diagnostic criteria for early vs. later studies did not reach statistical significance, later studies tended to use normal EEG background (p = 0.09) and absence of comorbid disorders (p = 0.09) as criteria more commonly. These findings demonstrate that seizure-freedom off medications has improved in published CAE studies after 1985. Our results are limited due to retrospective analysis. Further work is needed with prospective, controlled trials to establish factors leading to improved long-term prognosis in CAE.",
keywords = "Childhood absence epilepsy, Epileptogenesis, Ethosuximide, Prognosis, Valproate",
author = "Elliot Morse and Kathryn Giblin and Chung, {Mi Hae} and Carolin Dohle and Berg, {Anne T.} and Hal Blumenfeld",
year = "2019",
month = "5",
doi = "10.1016/j.eplepsyres.2019.02.013",
language = "English (US)",
volume = "152",
pages = "7--10",
journal = "Epilepsy Research",
issn = "0920-1211",
publisher = "Elsevier",

}

TY - JOUR

T1 - Historical trend toward improved long-term outcome in childhood absence epilepsy

AU - Morse, Elliot

AU - Giblin, Kathryn

AU - Chung, Mi Hae

AU - Dohle, Carolin

AU - Berg, Anne T.

AU - Blumenfeld, Hal

PY - 2019/5

Y1 - 2019/5

N2 - We retrospectively analyzed published studies to investigate historical trends in outcome of childhood absence epilepsy (CAE). We included patients based on onset of absence seizures in childhood, 3 Hz bilateral spike-wave discharges on EEG, and availability of seizure-free outcome data. The primary endpoint was seizure-freedom off medications by study publication year. We also analyzed relationships between seizure-freedom and 1. treatment medication, and 2. CAE diagnostic criteria. We included 29 studies published 1945–2013, encompassing 2416 patients. Seizure-freedom off medications was higher for studies after 1985 versus before 1975 (82% versus 35%; p < 0.001). Ethosuximide and valproate were used more commonly after 1985, and patients previously treated with ethosuximide or valproate had higher seizure-freedom off medications than those treated only with other medications (64% versus 32%; χ 2 >10; p < 0.001). Although differences in diagnostic criteria for early vs. later studies did not reach statistical significance, later studies tended to use normal EEG background (p = 0.09) and absence of comorbid disorders (p = 0.09) as criteria more commonly. These findings demonstrate that seizure-freedom off medications has improved in published CAE studies after 1985. Our results are limited due to retrospective analysis. Further work is needed with prospective, controlled trials to establish factors leading to improved long-term prognosis in CAE.

AB - We retrospectively analyzed published studies to investigate historical trends in outcome of childhood absence epilepsy (CAE). We included patients based on onset of absence seizures in childhood, 3 Hz bilateral spike-wave discharges on EEG, and availability of seizure-free outcome data. The primary endpoint was seizure-freedom off medications by study publication year. We also analyzed relationships between seizure-freedom and 1. treatment medication, and 2. CAE diagnostic criteria. We included 29 studies published 1945–2013, encompassing 2416 patients. Seizure-freedom off medications was higher for studies after 1985 versus before 1975 (82% versus 35%; p < 0.001). Ethosuximide and valproate were used more commonly after 1985, and patients previously treated with ethosuximide or valproate had higher seizure-freedom off medications than those treated only with other medications (64% versus 32%; χ 2 >10; p < 0.001). Although differences in diagnostic criteria for early vs. later studies did not reach statistical significance, later studies tended to use normal EEG background (p = 0.09) and absence of comorbid disorders (p = 0.09) as criteria more commonly. These findings demonstrate that seizure-freedom off medications has improved in published CAE studies after 1985. Our results are limited due to retrospective analysis. Further work is needed with prospective, controlled trials to establish factors leading to improved long-term prognosis in CAE.

KW - Childhood absence epilepsy

KW - Epileptogenesis

KW - Ethosuximide

KW - Prognosis

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=85062467344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062467344&partnerID=8YFLogxK

U2 - 10.1016/j.eplepsyres.2019.02.013

DO - 10.1016/j.eplepsyres.2019.02.013

M3 - Article

C2 - 30856420

AN - SCOPUS:85062467344

VL - 152

SP - 7

EP - 10

JO - Epilepsy Research

JF - Epilepsy Research

SN - 0920-1211

ER -